Global regulatory authorities have been raising the expectation of incorporating quality by design (QbD) into pharmaceutical development.
In silico approaches streamline drug discovery
Owners of original biomedicines are fighting tooth and nail to prevent biosimilar approvals, with patents being the principal battleground
Lessons learned from a 60,000 square-foot project completed in 11 months
More accurate protein insights help researchers and pharmaceutical companies drive scientific breakthroughs
Western blotting separates proteins by size and shape with an electric field applied to a gel, and then targeted proteins are stained with antibodies
Acquisition complements Agilent’s market-leading separations and mass spectrometry solutions, expands pharma offerings